Coronary Artery Spasm

  • Philip D. Henry
Part of the Developments in Cardiovascular Medicine book series (DICM, volume 34)

Abstract

Allan Burns (1809) {1}, medical school dropout and brilliant autodidact, was the first to propose that angina during exercise was due to myocardial ischemia. He believed that diseased coronary arteries acted as constricted rigid tubes which limited blood supply to the myocardium and generated a state in which the heart’s “energy supply and its energy expenditure do not balance each other”. According to this concept it is an increased work load on the heart that precipitates myocardial ischemia and anginal symptoms. However, already Herber-den (1772) {2} had recognized that angina may occur at rest, often during the night, a phenomenon that cannot be readily explained on the basis of Burns’ mechanism. During the 19th century, many authors felt that anginal pain was triggered by some distention of the aorta or left ventricle. Such cardiovascular dis-tentions were sometimes thought to occur as a result of peripheral constrictor responses, a syndrome that had been outlined by Nothnagel (1867) {3} under the name “angina pectoris vasomotoria”. Latham (1876) {4} and others believed that angina might reflect a cramp or spasm of the heart, but such a mechanism was not widely accepted, since it was thought that a cramp of the heart was not compatible with survival {5}. In the first edition of his textbook, Osier (1892) {6} discussed the possiblity that cardiac pain “resulted from the great stretching and tension of the nerves in the muscular substance”. He added that “a modified form of this view is that there is a spasm of the coronary arteries with great increase in the intracardiac pressure”. Osier was still under the influence of the mechanistic hypotheses of the 19th century. However, in his second Lumleian lecture on angina pectoris 18 years later (1910) {7}, his “modified view” became explicit. He discussed the possible role of coronary artery spasm at great length, and indicated that angina may be associated with other vasomotor disturbances such as Raynaud disease or migraine. On the basis of his clinical observations, he concluded that there was “evidence that sclerotic arteries are specially prone to spasm”. Also, he speculated that coronary vessels might be affected by a “perverted internal secretion which favours spasm of the arteries”. Therefore, the 19th century, era of speculations and controversies, generated two seemingly contradictory “coronary theories”: Burns’ rigid arteries, an example of insufficient vasomotion, and Osler’s atherosclerotic vasospasm, an example of excessive vasomotion.

Keywords

Migraine Serotonin Epinephrine Acetylcholine Verapamil 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Burns A: Observations on some account of the most frequent and important diseases of the heart. Edinburgh: J Muirhead, 1809, pp 136–163.Google Scholar
  2. 2.
    Herberden W: Some account of a disorder of the breast. R Coll Phys Med Trans 2: 59–67, 1772.Google Scholar
  3. 3.
    Nothnagel H: Angina pectoris vasomotoria. Dts Arch Klin Med 3: 309–322, 1867.Google Scholar
  4. 4.
    Latham PM: Collected works, vol 1. London: New Sydenham Society, 1876. Lecture 37, pp 445–463.Google Scholar
  5. 5.
    Hale EM: Lectures on diseases of the heart. New York: Boericke and Tafel, 1871, p 56.Google Scholar
  6. 6.
    Osier W: The principles and practice of medicine. New York: WD Appleton and Co, 1892, p 656.Google Scholar
  7. 7.
    Osier W: The Lumleian lectures on angina pectoris: lecture II. Lancet 1: 839–844, 1910.Google Scholar
  8. 8.
    Smith FM: The ligation of coronary arteries with electrocardiographic study. Arch Intern Med 22: 827, 1918.Google Scholar
  9. 9.
    Pardee HEB: An electrocardiographic sign of coronary artery obstruction. Arch Intern Med 26: 244257, 1920.Google Scholar
  10. 10.
    Parkinson J, Bedford DE: Electrocardiographic changes during brief attacks of angina pectoris. Lancet 1: 15–19, 1931.CrossRefGoogle Scholar
  11. 11.
    Wilson FN, Johnston FD: The occurrence in angina pectoris of electrocardiographic changes similar in magnitude and in kind to those produced by myocardial infarction. Am Heart J 22: 64–74, 1941.CrossRefGoogle Scholar
  12. 12.
    Sanazaro PJ: Transient electrocardiographic changes simulating acute myocardial infarction. Am Heart J 51: 149–155, 1956.PubMedCrossRefGoogle Scholar
  13. 13.
    Roesler H, Bressler W: Transient electrocardiographic changes identical with those of acute myo- cardial infarction accompanying attacks of angina pectoris. Am Heart J 47: 520–526, 1954.PubMedCrossRefGoogle Scholar
  14. 14.
    Hausner E, Scherf D: Uber Angina Pectoris Probleme. Z Klin Med 126: 166–193, 1933.Google Scholar
  15. 15.
    Brow GR, Holman DV: Electrocardiographic study during a paroxysm of angina pectoris. Am Heart J 9: 259–264, 1933.CrossRefGoogle Scholar
  16. 16.
    Prinzmetal J, Kennamer R, Merliss R, Wada T, Bor N: Angina pectoris. I. A variant form of angina pectoris: preliminary report. Am J Med 27: 375388, 1959.Google Scholar
  17. 17.
    Arnulf G: Étude artériographique de la vasomotricité coronarienne chez l’animal et chez l’homme. Presse Med 67: 2055–2057, 1959.PubMedGoogle Scholar
  18. 18.
    Gensini GG, Di Giorgi S, Murad-Netto S, Black A: Arteriographic demonstration of coronary artery spasm and its release after the use of a vasodilator in a case of angina pectoris and in the experimental animal. Angiology 13: 550–553, 1962.PubMedCrossRefGoogle Scholar
  19. 19.
    Demany MA, Tambe A, Zimmerman HA: Coronary arterial spasm. Dis Chest 53: 714–721, 1968.PubMedCrossRefGoogle Scholar
  20. 20.
    Dhurandhar RW, Walt DL, Silver MD, Trimble AS, Adelman AG: Prinzmetal’s variant form of angina with arteriographic evidence of coronary arterial spasm. Am J Cardiol 30: 902–905, 1972.PubMedCrossRefGoogle Scholar
  21. 21.
    Guazzi M, Olivari MT, Polese A, Fiorentini C, Margrini F: Repetitive myocardial ischemia of Prinzmetal type without angina pectoris. Am J Cardiol 37: 923–927, 1976.PubMedCrossRefGoogle Scholar
  22. 22.
    Meller J, Conde CA, Donoso E, Dack S: Transient Q waves in Prinzmetal’s angina. Am J Cardiol 35: 691–695, 1975.PubMedCrossRefGoogle Scholar
  23. 23.
    Maseri A, Severi S, De Nes M, l’Abbate M, Chier-chia A, Marzilli M, Ballestra A-M, Parodi O, Biagini A, Distante A: “Variant” angina: one aspect of a continuous spectrum of vasospastic myocardial ischemia. Am J Cardiol 42: 1019–1035, 1978.PubMedCrossRefGoogle Scholar
  24. 24.
    Madias JE: The syndrome of variant angina culminating in acute myocardial infarction. Circulation 59: 297–306, 1979.PubMedCrossRefGoogle Scholar
  25. 25.
    Boden WE, Bough EW, Benham I, Shulman RS: Unstable angina with episodic ST segment elevation and minimal creatine kinase release culminating in extensive, recurrent infarction. J Am Coll Cardiol 1: 11–20, 1983.CrossRefGoogle Scholar
  26. 26.
    Bentley KI, Clark M, Henry PD: Angiographic dye relaxes canine coronary artery by a non-osmotic mechanism. Am J Cardiol 47: 407, 1981.CrossRefGoogle Scholar
  27. 27.
    Morris TW, Katzberg RW, Fischer HW: A comparison of the hemodynamic responses to metrizamide and meglumine/sodium diatrizoate in canine renal angiography. Invest Radiol 13: 74–78, 1978.PubMedCrossRefGoogle Scholar
  28. 28.
    Arnett EN, Roberts WC: Acute myocardial infarction and angiographically normal coronary arteries: an unproven combination. Circulation 53: 395–400, 1976.PubMedCrossRefGoogle Scholar
  29. 29.
    Marcus ML, Armstrong ML, Heistad DD, Eastham CL, Mark AL: Comparison of three methods of evaluating coronary obstructive lesions: postmortem arteriography, pathologic examination and measure- ment of regional myocardial perfusion during maximal vasodilation. Am J Cardiol 49: 1699 1706, 1982.Google Scholar
  30. 30.
    MacAlpin RN: Contribution of dynamic vascular wall thickening to luminal narrowing during coronary arterial constriction. Circulation 61: 296–301, 1980.PubMedCrossRefGoogle Scholar
  31. 31.
    Bennett KR: Coronary artery spasm: the effect of cardiovascular laboratory. Cathet Cardiovasc Diagn 2: 321–327, 1976.PubMedCrossRefGoogle Scholar
  32. 32.
    Leary T: Coronary spasm as a possible factor in producing sudden death. Am Heart J 10: 338–344, 1935.CrossRefGoogle Scholar
  33. 33.
    Sewell WH: Coronary spasm as a primary cause of myocardial infarction. Angiology 17: 1–8, 1966.PubMedCrossRefGoogle Scholar
  34. 34.
    Oliva PB, Breckinridge JC: Arteriographic evidence of coronary arterial spasm in acute myocardial infarction. Circulation 56: 366–374, 1977.PubMedCrossRefGoogle Scholar
  35. 35.
    Johnson AD, Detwiler JH: Coronary spasm, variant angina, and recurrent myocardial infarctions. Circulation 55: 947–950, 1977.PubMedCrossRefGoogle Scholar
  36. 36.
    Maseri A, l’Abbate A, Baroldi G, Chierchia S, Marzilli M, Ballestra AM, Severi S, Parodi O, Biagini A, Distante A, Pesola A: Coronary vasospasm as a possible cause of myocardial infarction. N Engl J Med 299: 1271–1277, 1978.PubMedCrossRefGoogle Scholar
  37. 37.
    El-Maraghi NRH, Sealey BJ: Recurrent myocardial infarction in a young man due to coronary arterial spasm demonstrated at autopsy. Circulation 61: 199–207, 1980.PubMedCrossRefGoogle Scholar
  38. 38.
    Vincent GM, Anderson JL, Marshall HW: Coronary spasm producing coronary thrombosis and myocardial infarction. N Engl J Med 309: 220–223, 1983.PubMedCrossRefGoogle Scholar
  39. 39.
    Angoli L, Marinoni GP, Falcone C, Bramucci E, De Servi S, Specchia G, Montemartini C: Spasme coronarien a l’effort: demonstration coronarographique d’un cas. Arch Mal Coeur 71: 823–826, 1978.PubMedGoogle Scholar
  40. 40.
    Yasue H, Omote S, Takizawa A, Nagao M, Miwa K, Tanaka S: Exertional angina pectoris caused by coronary arterial spasm: effects of various drugs. Am J Cardiol 43: 647–652, 1979.PubMedCrossRefGoogle Scholar
  41. 41.
    Brouster JP, Griffo R, Series E, Guern P, Laylavoix F: Angor de Prinzmetal déclenché par l’arrêt de l’effort: cinq cas a coronarographie normale. Arch Mal Coeur 72: 391–400, 1979.Google Scholar
  42. 42.
    Waters DD, Chaitman BR, Dupras G, Théroux P, Mizgala HF: Coronary artery spasm during exercise in patients with variant angina. Circulation 52: 580–585, 1979.CrossRefGoogle Scholar
  43. 43.
    Yasue H, Omote S, Takizawa A, Nagao M, Miwa K, Tanaka S: Circadian variation of exercise capacity in patients with Prinzmetal’s variant angina: role of exercise-induced coronary arterial spasm. Circulation 59: 938–948, 1979.PubMedCrossRefGoogle Scholar
  44. 44.
    Specchia G, De Servi S, Falcone C, Bramucci E, Angoli L, Mussini A, Marinoni GP, Montemartini C, Bobba P: Coronary arterial spasm as a cause of exercise-induced ST-segment elevation in patients with variant angina. Circulation 59: 948–954, 1979.PubMedCrossRefGoogle Scholar
  45. 45.
    Waters DD, Szlachcic J, Bonan R, Miller DD, Dauwe F, Théroux P: Comparative sensitivity of exercise, cold pressor and ergonovine testing in provoking attacks of variant angina in patients with active disease. Circulation 67: 310–315, 1983.PubMedCrossRefGoogle Scholar
  46. 46.
    Kimura E, Hosoda S, Katoh K, Endo M, Yasue H, Asada S, Kuroiwa A: Panel discussion on the variant form of angina pectoris. Jpn Circ J 42: 455476, 1978.Google Scholar
  47. 47.
    Sakanashi M: Pharmacological aspects of coronary arterial spasm. TIPS 2: 234–236, 1981.Google Scholar
  48. 48.
    Ganz W: Coronary spasm in myocardial infarction: fact or fiction? Circulation 63: 487–488, 1981.PubMedCrossRefGoogle Scholar
  49. 49.
    Koiwaya Y, Torii S, Takeshita A, Nakagaki O, Nakamura M: Postinfarction angina caused by coronary arterial spasm. Circulation 65: 275–280, 1982.PubMedCrossRefGoogle Scholar
  50. 50.
    Ku DD: Coronary vascular reactivity after acute myocardial ischemia. Science 218: 576–578, 1982.PubMedCrossRefGoogle Scholar
  51. 51.
    Kimura E, Tanaka K, Mizuno K, Honda Y, Hashimoto H: Suppression of repeatedly occurring ventricular fibrillation with nifedipine in variant form of angina pectoris. Jpn Heart J 18: 736–742, 1977.PubMedCrossRefGoogle Scholar
  52. 52.
    Campbell TJ, Hickie JB, Michell G, O’Rourke MF: Nifedipine in the treatment of life threatening Prinzmetal angina. Aust NZ J Med 9: 293–294, 1979.CrossRefGoogle Scholar
  53. 53.
    Miller DD, Waters DD, Szlachcic J, Théroux P: Clinical characteristics associated with sudden death in patients with variant angina. Circulation 66: 588–592, 1982.PubMedCrossRefGoogle Scholar
  54. 54.
    Waters DD, Bouchard A, Théroux P: Spontaneous remission is a frequent outcome of variant angina. J Am Coll Cardiol 2: 195–199, 1983.PubMedCrossRefGoogle Scholar
  55. 55.
    Bott-Silverman C, Heupler FA: Natural history of pure coronary artery spasm in patients treated medically. J Am Coll Cardiol 2: 200–205, 1983.PubMedCrossRefGoogle Scholar
  56. 56.
    Heupler FA: Syndrome of symptomatic coronary arterial spasm with nearly normal coronary arteriograms. Am J Cardiol 45: 873–881, 1980.PubMedCrossRefGoogle Scholar
  57. 57.
    Selzer A, Langston M, Ruggeroli C, Cohn K: Clinical syndrome of variant angina with normal coronary arteriogram. N Engl J Med 295: 1343–1347, 1976.PubMedCrossRefGoogle Scholar
  58. 58.
    Wissler RW, Vesselinovitch D: Atherosclerosis: relationship to coronary blood flow. Am J Cardiol 52: 2A - 7A, 1983.PubMedCrossRefGoogle Scholar
  59. 59.
    Peretz DI: Variant angina pectoris of Prinzmetal. Can Med Assoc J 85: 1101–1102, 1961.PubMedGoogle Scholar
  60. 60.
    Mériel P, Galinier F, Bounhoure J-P, Mignon J-P, Salvador M: Onde monophasique et tachycardie ventriculaire dans l’angor spontané de type Prinz-metal. Arch Mal Coeur 59: 460–465, 1966.Google Scholar
  61. 61.
    Gianelly R, Mugler F, Harrison DC: Prinzmetal’s variant of angina pectoris with only slight coronary atherosclerosis. Calif Med 108: 129–132, 1968.PubMedGoogle Scholar
  62. 62.
    Benhaim R, Calvo G, Seban C, Tarrade T, Chiche P: Les aspects anatomiques de l’angor de Prinzme- tal: à propos d’une observation anatomoclinique. Arch Mal Coeur 68: 189–197, 1975.Google Scholar
  63. 63.
    Poggi L, Bory M, Djiane P, d’Journo J, Serradimigni A: Les lesions anatomiques dans l’angor spontané de Prinzmetal. Marseille Med 109: 39–41, 1972.PubMedGoogle Scholar
  64. 64.
    Guermonprez JL, Gueret P, Camilleri JP, Guerinon J, Deloche A, Maurice P: Angor de Prinzmetal, Etude histologique coronaire de prélévements peroperatoires. Arch Mal Coeur 70: 301–308, 1977.PubMedGoogle Scholar
  65. 65.
    Petitier H, De Lajartre AY, Geslin Ph, Godin JF, Victor J, Crochet D, Dupon H: Dysplasie fibreuse intimale coronaire et angor de Prinzmetal. Arch Mal Coeur 71:963–1438 and 1053–1059, 1978.Google Scholar
  66. 66.
    Fievez M, Philippart F, Hustin J: Communications to the editor. Angiology 26: 491–498, 1975.CrossRefGoogle Scholar
  67. 67.
    Von Storch TJC: Complications following the use of ergotamine tartrate. JAMA 111: 293–300, 1938.Google Scholar
  68. 68.
    Goldfischer JD: Acute myocardial infarction secondary to ergot therapy. N Engl J Med 262: 860–863, 1960.CrossRefGoogle Scholar
  69. 69.
    Labbé M, Boulin R, Justin-Besancon G: L’Angine de poitrine ergotaminique. Presse Med 66: 1069, 1929.Google Scholar
  70. 70.
    Nordenfelt O: Über functionelle Veränderungen der P und T-Zacken im Elektrokardiogramm. Acta Med Scand Suppl 119: 1, 1941.Google Scholar
  71. 71.
    Master AM, Pordy L, Kolker J: Ergotamine tartrate and the “two step” exercise electrocardiogram in functional cardiac disturbance. J Mt Sinai Hosp 15: 164–168, 1948.Google Scholar
  72. 72.
    Scherf D, Schlachman M: Electrocardiographic and clinical studies on the action of ergotamine tartrate and dihydro-ergotamine. Am J Med Sci 216: 673679, 1948.Google Scholar
  73. 73.
    Stein I: Observations on the action of ergonovine on the coronary circulation and its use in the diagnosis of coronary artery insufficiency. Am Heart J 37: 3645, 1949.CrossRefGoogle Scholar
  74. 74.
    Heupler FA, Proudfit WL, Razavi M, Shirey EK, Greenstreet R, Sheldon WC: Ergonovine maleate provocative test for coronary arterial spasm. Am J Cardiol 41: 631–640, 1978.PubMedCrossRefGoogle Scholar
  75. 75.
    Curry RC, Pepine CJ, Sabom MB, Conti CR: Similarities of ergonovine-induced and spontaneous attacks of variant angina. Circulation 59: 307–312, 1979.PubMedCrossRefGoogle Scholar
  76. 76.
    Théroux P, Waters DD, Affaki GS, Crittin J, Bonan R, Mizgala HF: Provocative testing with ergonovine to evaluate the efficacy of treatment with calcium antagonists in variant angina. Circulation 60: 504–509, 1979.PubMedCrossRefGoogle Scholar
  77. 77.
    Cipriano PR, Guthaner DF, Orlick AE, Ricci DR, Wexler L, Silverman JF: The effects of ergonovine maleate on coronary arterial size. Circulation 59: 82–89, 1979.PubMedCrossRefGoogle Scholar
  78. 78.
    Cannon RO, Watson RM, Rosing DR, Epstein SE: Angina caused by reduced vasodilator reserve of the small coronary arteries. J Am Coll Cardiol 1:1359–1373, 1983.Google Scholar
  79. 79.
    Berde B, Sturmer E: Introduction to the pharmacology of ergot alkaloids and related compounds as a basis of their therapeutic application. In: Berde B, Schild HO (eds) Berlin: Ergot alkaloids and related compounds. Springer-Verlag, 1978, pp 1–23.Google Scholar
  80. 80.
    Müller-Schweinitzer E: The mechanism of ergometrine-induced coronary arterial spasm: in vitro studies on canine arteries. J Cardiovasc Pharmacol 2: 645–655, 1980.PubMedCrossRefGoogle Scholar
  81. 81.
    Sakanashi M, Yonemura K-I: On the mode of action of ergometrine in the isolated dog coronary artery. Eur J Pharmacol 64: 157–160, 1980.PubMedCrossRefGoogle Scholar
  82. 82.
    Brazenor RM, Angus JA: Ergometrine contracts isolated canine coronary arteries by a serotonergic mechanism: no role for alpha adrenoceptors. J Pharmacol Exp Ther 218: 530–536, 1981.PubMedGoogle Scholar
  83. 83.
    Holtz J, Held W, Sommer O, Kühne G, Bassenge E: Ergonovine-induced constrictions of epicardial coronary arteries in conscious dogs: a-adrenoceptors are not involved. Basic Res Cardiol 77: 278–291, 1982.PubMedCrossRefGoogle Scholar
  84. 84.
    Henry PD: Coronary constriction as a pathogenic mechanism of myocardial ischemia. In: De Bakey ME, Gotto AM (eds) Factors influencing the course of myocardial ischemia. Amsterdam: Elsevier Biomedical, 1983, pp 123–133.Google Scholar
  85. 85.
    Orlick AE, Ricci DR, Alderman EL, Stinson EB, Harrison DC: Effects of alpha adrenergic blockade upon coronary hemodynamics. J Clin Invest 62: 459–467, 1978.PubMedCrossRefGoogle Scholar
  86. 86.
    Mudge GH, Grossman W, Mills RM, Lesch M, Braunwald E: Reflex increase in coronary vascular resistance in patients with ischemic heart disease. N Engl J Med 295: 1333–1337, 1976.PubMedCrossRefGoogle Scholar
  87. 87.
    Levene DL, Freeman MR: a-Adrenoceptor-mediated coronary artery spasm. JAMA 236: 1018 1052, 1976.Google Scholar
  88. 88.
    Yasue H, Touyama M, Shimamoto M, Kato H, Tanaka S, Akiyama F: Role of autonomic nervous system in the pathogenesis of Prinzmetal’s variant form of angina. Circulation 50: 534, 1974.PubMedCrossRefGoogle Scholar
  89. 89.
    Yasue H, Youyama M, Kato H, Tanaka S, Akiyama F: Prinzmetal’s variant form of angina as a manifestation of alpha-adrenergic receptor-mediated coronary artery spasm: documentation by coronary arteriography. Am Heart J 91: 148–155, 1976.PubMedCrossRefGoogle Scholar
  90. 90.
    Ricci DR, Orlick AE, Cipriano PR, Guthaner DF, Harrison DC: Altered adrenergic activity in coronary arterial spasm: insight into mechanism based on study of coronary hemodynamics and the electrocardiogram. Am J Cardiol 43: 1073–1079, 1979.PubMedCrossRefGoogle Scholar
  91. 91.
    Bertrand ME, Lablanche JM, Rousseau MF, Warembourg HH, Stankowtak C, Soots G: Surgical treatment of variant angina: use of plexectomy with aortocoronary bypass. Circulation 61: 877–882, 1980.PubMedCrossRefGoogle Scholar
  92. 92.
    Bertrand ME, Lablanche JM, Tilmant PY, Ducloux G, Warembourg H, Soots G: Complete denervation of the heart (autotransplantation) for treatment of severe, refractory coronary spasm. Am J Cardiol 47: 1375–1378, 1981.PubMedCrossRefGoogle Scholar
  93. 93.
    Chierchia S, Davies G, Gerkenboom G, Crea F, Crean P, Maseri A: Alpha-adrenergic receptors and coronary spasm: an elusive link. Circulation 69: 814, 1984.CrossRefGoogle Scholar
  94. 94.
    Buda AJ, Fowles RE, Schroeder JS, Hunt SA, Cipriano PR, Stinson EB, Harrison DC: Coronary artery spasm in the denervated transplanted human heart. Am J Med 70: 1144–1149, 1981.PubMedCrossRefGoogle Scholar
  95. 95.
    Weber S, Donzeau-Gouge G-P, Chauvaud S, Picard G, Guerin F, Carpentier A, Degeorges M: Assessment of plexectomy in the treatment of severe coronary spasm in patients with normal coronary arteries. Am J Cardiol 51: 1072–1076, 1983.PubMedCrossRefGoogle Scholar
  96. 96.
    Robertson D, Robertson RM, Nies AS, Oates JA, Friesinger GC: Variant angina pectoris: investigation of indexes of sympathetic nervous system function. Am J Cardiol 43: 1080–1085, 1979.PubMedCrossRefGoogle Scholar
  97. 97.
    Yasue H, Omote S, Takizawa A, Nagao M, Miwa K, Kato H, Tanaka S, Akiyama F: Pathogenesis and treatment of angina pectoris at rest as seen from its response to various drugs. Jpn Circ J 42: 1–10, 1978.PubMedCrossRefGoogle Scholar
  98. 98.
    Robertson RM, Wood AJJ, Vaughn WK, Robertson D: Exacerbation of vasotonic angina pectoris by propranolol. Circulation 65: 281–285, 1982.PubMedCrossRefGoogle Scholar
  99. 99.
    Tilmant PY, Lablanche JM, Thieuleux FA, Dupuis BA, Bertrand ME: Detrimental effect of propranolol in patients with coronary arterial spasm countered by combination with diltiazem. Am J Cardiol 52: 230–233, 1983.PubMedCrossRefGoogle Scholar
  100. 100.
    Ginsburg R, Bristow MR, Kantrowitz N, Bairn DS, Harrison DC: Histamine provocation of clinical coronary artery spasm: implications concerning pathogenesis of variant angina pectoris. Am Heart J 102: 819–822, 1981.PubMedCrossRefGoogle Scholar
  101. 101.
    Henry PD, Yokoyama M: Inappropriate coronary vasomotion: search for a local fault. In: Rafflenbeul W, Lichtlen PR, Balcon R (eds) Unstable angina pectoris. Stuttgart; G Thieme, New York, 1981, pp 18–23.Google Scholar
  102. 102.
    Van Nueten JM, Janssen PAJ, Van Beek J, Xhonneux R, Verbeuren TJ, Vanhoutte PM: Vascular effects of ketanserin (R 41 468), a novel antagonist of 5-HT2 serotonergic receptors. J Pharmacol Exp Ther 218: 217–230, 1981.PubMedGoogle Scholar
  103. 103.
    Personal communications: Drs ME Bertrand, Lille, France; DD Waters, Montreal, Canada; and S Chiercha, London, England.Google Scholar
  104. 104.
    Endo M, Hirosawa K, Kaneko N, Hase K, Inoue Y, Konno S: Prinzmetal’s variant angina. N Engl J Med 294: 252–255, 1976.PubMedCrossRefGoogle Scholar
  105. 105.
    Furchgott RF, Zawadzki JV: The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288: 373–376, 1980.PubMedCrossRefGoogle Scholar
  106. 106.
    Frank GW, Bevan JA: Electrical stimulation causes endothelium-dependent relaxation in lung vessels. Am J Physiol 244: H793 — H798, 1983.PubMedGoogle Scholar
  107. 107.
    Ignarro LJ, Lippton H, Edwards JC, Baricos WH, Hyman AL, Kadowitz PJ, Gruetter CA: Mechanism of vascular smooth muscle relaxation by organic ni- crates, nitrites, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates. J Pharmacol Exp Ther 218: 739749, 1981.Google Scholar
  108. 108.
    Lange RL, Reid MS, Tresch DD, Keelan MH, Bernhard VM, Coolidge G: Nonatheromatous ischemic heart disease following withdrawal from chronic industrial nitroglycerin exposure. Circulation 46: 666–678, 1972.PubMedCrossRefGoogle Scholar
  109. 109.
    Ross G, Stinson E, Schroeder J, Ginsburg R: Spontaneous phasic activity of isolated human coronary arteries. Cardiovasc Res 14: 613–618, 1980.PubMedCrossRefGoogle Scholar
  110. 110.
    Ginsburg R, Bristow MR, Harrison DC, Stinson EB: Studies with isolated human coronary arteries. Chest 78: 180–186, 1980.PubMedGoogle Scholar
  111. 111.
    Speralakis N: Electrophysiology of vascular smooth muscle of coronary artery. In: Kalsner S (ed) The coronary artery. London: Croom Helm, 1982, pp 118–166.Google Scholar
  112. 112.
    Dembinska-Kiec A, Gryglewska T, Zmunda A, Gryglewski RJ: The generation of prostacyclin by arteries and by the coronary vascular bed is reduced in experimental atherosclerosis in rabbit. Prostaglandins 14: 1025–1034, 1977.PubMedCrossRefGoogle Scholar
  113. 113.
    Angelo VD, Villa S, Mysliwiec M, Donati MB, De Gaetaso G: Defective fibrinolitic and prostacyclin like activity in human atheromatous plaques. Thromb Diath Haem 39: 535–536, 1978.Google Scholar
  114. 114.
    Folts JD, Gallagher K, Rowe GG: Blood flow reductions in stenosed canine coronary arteries: vasospasm or platelet aggregation? Circulation 65: 248255, 1982.Google Scholar
  115. 115.
    Martin TJ, Smith IL, Nolan RD, Dusting GJ: Prostanoids in platelet-vascular interactions. Am J Cardiol 52: 22A - 27A, 1983.PubMedCrossRefGoogle Scholar
  116. 116.
    Robertson RM, Robertson D, Roberts LJ, Maas RL, FitzGerald GA, Friesinger GC, Oates JA: Thromboxane A2 in vasotonic angina pectoris. N Engl J Med 304: 998–1003, 1981.PubMedCrossRefGoogle Scholar
  117. 117.
    Hirsh PD, Hillis LD, Campbell WB, Firth BG, Willerson JT: Release of prostaglandins and thromboxane into the coronary circulation in patients with ischemic heart disease. N Engl J Med 304: 685–691, 1981.PubMedCrossRefGoogle Scholar
  118. 118.
    Chand N, Altura BM: Acetylcholine and bradykinin relax intrapulmonary arteries by acting on endothelial cells: role in lung vascular diseases. Science 213: 1376–1379, 1981.PubMedCrossRefGoogle Scholar
  119. 119.
    Shattil SJ, Anaya-Galindo R, Bennett J, Colman RW, Cooper RA: Platelet hypersensitivity induced by cholesterol incorporation. J Clin Invest 55: 636643, 1975.Google Scholar
  120. 120.
    Henry PD, Yokoyama M: Supersensitivity of atherosclerotic rabbit aorta to ergonovine: mediation by a serotonergic mechanism. J Clin Invest 66: 306313, 1980.Google Scholar
  121. 121.
    Nanda V, Henry PD: Increased serotonergic and al-pha adrenergic receptors in aortas from rabbits fed a high cholesterol diet. Clin Res 30: 209A, 1982.Google Scholar
  122. 122.
    Yokoyama M, Henry PD: Sensitization of isolated canine coronary arteries to calcium ions after exposure to cholesterol. Circ Res 45: 479–486, 1979.PubMedCrossRefGoogle Scholar
  123. 123.
    Shimokawa H, Tomoike H, Nakeyama S, Yamamoto H, Araki H, Nakamura M: Coronary artery spasm induced in atherosclerotic miniature swine. Science 221: 560–561, 1983.PubMedCrossRefGoogle Scholar
  124. 124.
    Voudoukis IJ: Exaggerated cold-pressor response in hypertensive patients with superimposed arteriosclerosis. J Surg Oncol 2: 83–87, 1970.PubMedCrossRefGoogle Scholar
  125. 125.
    Perez JE, Saffitz JE, Gutierrez FA, Henry PD: Coronary artery spasm in intact dogs induced by potassium and serotonin. Circ Res 52: 423–431, 1983.PubMedCrossRefGoogle Scholar
  126. 126.
    Turlapaty PDMV, Altura BM: Magnesium deficiency produces spasms of coronary arteries: relationship to etiology of sudden death ischemic heart disease. Science 208: 198–200, 1980.PubMedCrossRefGoogle Scholar
  127. 127.
    Yasue H, Nagao M, Omote S, Takizawa A, Miwa K, Tanaka S: Coronary arterial spasm and Prinz-metal’s variant form of angina induced by hyperventilation and tris-buffer infusion. Circulation 58: 5662, 1978.CrossRefGoogle Scholar
  128. 128.
    Kimura E, Kishida H: Treatment of variant angina with drugs: a survey of 11 cardiology institutes in Japan. Circulation 63L: 844, 1981.PubMedCrossRefGoogle Scholar
  129. 129.
    Antman E, Muller JE, Goldberg S, MacAlpin R, Rubenfine M, Tabatznid B, Liang C, Heupler F, Achuff S, Reichek N, Geltman E, Kerin NZ, Neff RK, Braunwald E: Nifedipine therapy for coronary artery spasm: experience in 127 patients. N Engl J Med 302: 1269–1273, 1980.PubMedCrossRefGoogle Scholar
  130. 130.
    Henry PD, Perez JE: Clinical pharmacology of calcium antagonists. In: Brest AN (ed) Cardiovascular clinics. Philadelphia: FA Davis, 1984, 93–109.Google Scholar
  131. 131.
    Hill JA, Feldman RL, Pepine CJ, Conti CR: Randomized double-blind comparison of nifedipine isosorbide dinitrate in patients with coronary arterial spasm. Am J Cardiol 49: 431–437, 1982.PubMedCrossRefGoogle Scholar
  132. 132.
    Bühler FR, Hulthén L: Calcium channel blockers: a pathophysiologically based hypertensive treatment concept for the future? Eur J Clin Invest 12: 1–3, 1982.PubMedCrossRefGoogle Scholar
  133. 133.
    Chierchia S, Patrono C, Crea F, Ciabattoni G, De Caterina R, Cinotti GA, Distante A, Maseri A: Effects of intravenous prostacyclin in variant angina. Circulation 65: 470–477, 1982.PubMedCrossRefGoogle Scholar
  134. 134.
    Chierchia S, De Caterina R, Crea F, Patrono C, Maseri A: Failure of thromboxane AZ blockade to prevent attacks of vasospastic angina. Circulation 66: 702–705, 1982.PubMedCrossRefGoogle Scholar
  135. 135.
    David PR, Waters DD, School J-M, Crepeau J, Szlachcic J, Lesperance J, Hudon G, Bourassa G: Percutaneous transluminal coronary angioplasty in patients with variant angina. Circulation 66: 695702, 1982.Google Scholar

Copyright information

© Springer Science+Business Media Dordrecht 1984

Authors and Affiliations

  • Philip D. Henry

There are no affiliations available

Personalised recommendations